Discontinued — last reported Q2 '24
Edwards Lifesciences Estimated litigation liability decreased by 60.8% to $57.30M in Q1 2026 compared to the prior quarter.
other_litigation_reserve| Q4 '24 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|
| Value | $10.50M | $85.50M | $146.20M | $57.30M |
| QoQ Change | — | +714.3% | +71.0% | -60.8% |
| YoY Change | — | — | >999% | — |